SynCardia Systems, LLC, LLC, manufacturer of the world's only clinical...
Inovio Pharmaceuticals has announced its novel therapy INO-3106 agains...
Johnson & Johnson announced that it has completed the divestiture ...
Johnson & Johnson announced that its subsidiary Ethicon has comple...
Merck discloses it’s BioContinuum™ Buffer Delivery Pl...
As part of its Diagnostics Accelerator research program, the Alzheimer...
C3J Therapeutics, a private clinical stage biotechnology co...
Puma Biotechnology and Pierre Fabre have entered into an exclusive lic...
Merck has announced an investment of €150 million in its manufact...
The Multiple Myeloma (MM) market is expected to grow from $14.5bn in 2...
Celgene Corporation has announced that the European Medicines Agency's...
Boehringer Ingelheim has announced that it acquired ICD Therapeut...
AstraZeneca is spearheading the creation of a new life sciences park, ...
Bristol-Myers Squibb and Concerto HealthAI, a company in oncology-spec...
Luye Pharma Group has announced submission of a new drug application (...
ProteoNic Biotechnology BV has licensed its 2G UNic™ t...
Eli Lilly and ImmuNext has announced a global licensing and resea...
CytoSMART, that develops and manufactures digital microscopes for moni...
